{"podcast":{"title":"Blood Podcast","slug":"blood-podcast-664776","podcast_index_feed_id":664776,"rss_url":"https://feeds.transistor.fm/blood-podcast","website_url":null,"image_url":"https://img.transistorcdn.com/WlMZsA1edpS0qEIavlrh9KLfCFShKE7FTJxZLlZsByw/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kY2Q4/YzJhZmMwODBjOWRi/YTNhN2Y1NWJkMzMw/NTBjZi5qcGc.jpg","author":"American Society of Hematology","episode_count":388,"summary":"The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.","last_synced_at":"2026-07-17T04:20:44.828596+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776"},"episodes":[{"title":"IV Iron during Acute Infection and Revisiting iTTP Refractoriness","slug":"iv-iron-during-acute-infection-and-revisiting-ittp-refractoriness","published_at":"2026-07-16T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/iv-iron-during-acute-infection-and-revisiting-ittp-refractoriness","url":"https://share.transistor.fm/s/87c31d14","duration_seconds":1005,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/iv-iron-during-acute-infection-and-revisiting-ittp-refractoriness/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/iv-iron-during-acute-infection-and-revisiting-ittp-refractoriness.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"A Pediatric ITP Risk Model and Targeting CD2 with CAR T-cell therapies","slug":"a-pediatric-itp-risk-model-and-targeting-cd2-with-car-t-cell-therapies","published_at":"2026-07-09T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/a-pediatric-itp-risk-model-and-targeting-cd2-with-car-t-cell-therapies","url":"https://share.transistor.fm/s/ce15a794","duration_seconds":1097,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/a-pediatric-itp-risk-model-and-targeting-cd2-with-car-t-cell-therapies/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/a-pediatric-itp-risk-model-and-targeting-cd2-with-car-t-cell-therapies.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"IV Iron Risks and Low-Dose AML Gains","slug":"iv-iron-risks-and-low-dose-aml-gains","published_at":"2026-07-02T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/iv-iron-risks-and-low-dose-aml-gains","url":"https://share.transistor.fm/s/c7970701","duration_seconds":1488,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/iv-iron-risks-and-low-dose-aml-gains/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/iv-iron-risks-and-low-dose-aml-gains.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Orca-T for GVHD–free survival and Understanding VEXAS anemia","slug":"orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia","published_at":"2026-06-25T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia","url":"https://share.transistor.fm/s/ae7ba399","duration_seconds":1384,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/orca-t-for-gvhd-free-survival-and-understanding-vexas-anemia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Treating AML, Before and After Relapse","slug":"treating-aml-before-and-after-relapse","published_at":"2026-06-18T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/treating-aml-before-and-after-relapse","url":"https://share.transistor.fm/s/2dbaa214","duration_seconds":973,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/treating-aml-before-and-after-relapse/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/treating-aml-before-and-after-relapse.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Future Directions in Relapsed and Refractory Large B-cell Lymphoma","slug":"future-directions-in-relapsed-and-refractory-large-b-cell-lymphoma","published_at":"2026-06-11T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/future-directions-in-relapsed-and-refractory-large-b-cell-lymphoma","url":"https://share.transistor.fm/s/de6fdfa2","duration_seconds":1518,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/future-directions-in-relapsed-and-refractory-large-b-cell-lymphoma/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/future-directions-in-relapsed-and-refractory-large-b-cell-lymphoma.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Review Series on Clonal Tracking in Hematopoiesis","slug":"review-series-on-clonal-tracking-in-hematopoiesis","published_at":"2026-06-04T16:00:17+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-clonal-tracking-in-hematopoiesis","url":"https://share.transistor.fm/s/1b247f77","duration_seconds":1825,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/review-series-on-clonal-tracking-in-hematopoiesis/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-clonal-tracking-in-hematopoiesis.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"New Approaches: Marstacimab Therapy and HLH Biomarkers","slug":"new-approaches-marstacimab-therapy-and-hlh-biomarkers","published_at":"2026-05-28T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/new-approaches-marstacimab-therapy-and-hlh-biomarkers","url":"https://share.transistor.fm/s/18f11dc5","duration_seconds":1070,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/new-approaches-marstacimab-therapy-and-hlh-biomarkers/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/new-approaches-marstacimab-therapy-and-hlh-biomarkers.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Review Series on Hemophagocytic Lymphohistiocytosis (HLH)","slug":"review-series-on-hemophagocytic-lymphohistiocytosis-hlh","published_at":"2026-05-21T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-hemophagocytic-lymphohistiocytosis-hlh","url":"https://share.transistor.fm/s/2d0678dd","duration_seconds":976,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/review-series-on-hemophagocytic-lymphohistiocytosis-hlh/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-hemophagocytic-lymphohistiocytosis-hlh.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"IBD augmentation of CHIP and Platelet mTOR's impact on Cerebral Malaria","slug":"ibd-augmentation-of-chip-and-platelet-mtor-s-impact-on-cerebral-malaria","published_at":"2026-05-14T16:00:36+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/ibd-augmentation-of-chip-and-platelet-mtor-s-impact-on-cerebral-malaria","url":"https://share.transistor.fm/s/7bcb593a","duration_seconds":1241,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/ibd-augmentation-of-chip-and-platelet-mtor-s-impact-on-cerebral-malaria/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/ibd-augmentation-of-chip-and-platelet-mtor-s-impact-on-cerebral-malaria.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Long-term efficacy and safety of betibeglogene autotemcel for β-thalassemia","slug":"long-term-efficacy-and-safety-of-betibeglogene-autotemcel-for-thalassemia","published_at":"2026-05-07T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/long-term-efficacy-and-safety-of-betibeglogene-autotemcel-for-thalassemia","url":"https://share.transistor.fm/s/b9b05532","duration_seconds":784,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/long-term-efficacy-and-safety-of-betibeglogene-autotemcel-for-thalassemia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/long-term-efficacy-and-safety-of-betibeglogene-autotemcel-for-thalassemia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Effects of ZNF467 on HSPC fitness and Promotion of Follicular Lymphoma via DC-SIGN","slug":"effects-of-znf467-on-hspc-fitness-and-promotion-of-follicular-lymphoma-via-dc-sign","published_at":"2026-04-30T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/effects-of-znf467-on-hspc-fitness-and-promotion-of-follicular-lymphoma-via-dc-sign","url":"https://share.transistor.fm/s/4821fe76","duration_seconds":1341,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/effects-of-znf467-on-hspc-fitness-and-promotion-of-follicular-lymphoma-via-dc-sign/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/effects-of-znf467-on-hspc-fitness-and-promotion-of-follicular-lymphoma-via-dc-sign.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Pathophysiology of ANKRD26-related thrombocytopenia and B-ALL recurrence after blinatumomab","slug":"pathophysiology-of-ankrd26-related-thrombocytopenia-and-b-all-recurrence-after-blinatumomab","published_at":"2026-04-23T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/pathophysiology-of-ankrd26-related-thrombocytopenia-and-b-all-recurrence-after-blinatumomab","url":"https://share.transistor.fm/s/f867a52e","duration_seconds":1164,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/pathophysiology-of-ankrd26-related-thrombocytopenia-and-b-all-recurrence-after-blinatumomab/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/pathophysiology-of-ankrd26-related-thrombocytopenia-and-b-all-recurrence-after-blinatumomab.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Real-world availability of CAR T-cell therapies","slug":"real-world-availability-of-car-t-cell-therapies","published_at":"2026-04-16T16:33:22+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/real-world-availability-of-car-t-cell-therapies","url":"https://share.transistor.fm/s/1a6a718d","duration_seconds":598,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/real-world-availability-of-car-t-cell-therapies/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/real-world-availability-of-car-t-cell-therapies.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Consequences of p53 loss and Gastrin for aGVHD of the Stomach","slug":"consequences-of-p53-loss-and-gastrin-for-agvhd-of-the-stomach","published_at":"2026-04-09T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/consequences-of-p53-loss-and-gastrin-for-agvhd-of-the-stomach","url":"https://share.transistor.fm/s/6e126e42","duration_seconds":1212,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/consequences-of-p53-loss-and-gastrin-for-agvhd-of-the-stomach/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/consequences-of-p53-loss-and-gastrin-for-agvhd-of-the-stomach.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Review Series on Myeloproliferative Neoplasms","slug":"review-series-on-myeloproliferative-neoplasms","published_at":"2026-04-02T16:06:14+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-myeloproliferative-neoplasms","url":"https://share.transistor.fm/s/5cf8c948","duration_seconds":1569,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/review-series-on-myeloproliferative-neoplasms/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-myeloproliferative-neoplasms.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"CH in children with SCD and Asciminib for CML in the ASC4FIRST trial","slug":"ch-in-children-with-scd-and-asciminib-for-cml-in-the-asc4first-trial","published_at":"2026-03-26T16:43:47+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/ch-in-children-with-scd-and-asciminib-for-cml-in-the-asc4first-trial","url":"https://share.transistor.fm/s/f8bc777b","duration_seconds":815,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/ch-in-children-with-scd-and-asciminib-for-cml-in-the-asc4first-trial/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/ch-in-children-with-scd-and-asciminib-for-cml-in-the-asc4first-trial.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Emerging Mechanisms: Neutrophils and Immune thrombocytopenia from ICI","slug":"emerging-mechanisms-neutrophils-and-immune-thrombocytopenia-from-ici","published_at":"2026-03-19T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/emerging-mechanisms-neutrophils-and-immune-thrombocytopenia-from-ici","url":"https://share.transistor.fm/s/1995031d","duration_seconds":1172,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/emerging-mechanisms-neutrophils-and-immune-thrombocytopenia-from-ici/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/emerging-mechanisms-neutrophils-and-immune-thrombocytopenia-from-ici.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Hepcidin-DMT1 interaction and GPRC5D-targeting bispecific antibody for MM","slug":"hepcidin-dmt1-interaction-and-gprc5d-targeting-bispecific-antibody-for-mm","published_at":"2026-03-12T16:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/hepcidin-dmt1-interaction-and-gprc5d-targeting-bispecific-antibody-for-mm","url":"https://share.transistor.fm/s/f752e487","duration_seconds":932,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/hepcidin-dmt1-interaction-and-gprc5d-targeting-bispecific-antibody-for-mm/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/hepcidin-dmt1-interaction-and-gprc5d-targeting-bispecific-antibody-for-mm.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"PETAL Consortium Survival Prognosticators and How Inflammation Impacts Hematopoiesis","slug":"petal-consortium-survival-prognosticators-and-how-inflammation-impacts-hematopoiesis","published_at":"2026-03-05T17:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/petal-consortium-survival-prognosticators-and-how-inflammation-impacts-hematopoiesis","url":"https://share.transistor.fm/s/65259fd5","duration_seconds":780,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/petal-consortium-survival-prognosticators-and-how-inflammation-impacts-hematopoiesis/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/petal-consortium-survival-prognosticators-and-how-inflammation-impacts-hematopoiesis.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Review Series on the Structural Underpinnings of Hemostatic Plugs and Thrombotic Occulsions","slug":"review-series-on-the-structural-underpinnings-of-hemostatic-plugs-and-thrombotic-occulsions","published_at":"2026-02-26T17:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-the-structural-underpinnings-of-hemostatic-plugs-and-thrombotic-occulsions","url":"https://share.transistor.fm/s/d7be0206","duration_seconds":1710,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/review-series-on-the-structural-underpinnings-of-hemostatic-plugs-and-thrombotic-occulsions/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/review-series-on-the-structural-underpinnings-of-hemostatic-plugs-and-thrombotic-occulsions.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"VTE Risk Model in Children and a Novel Tri-specific T-cell-engager for MM","slug":"vte-risk-model-in-children-and-a-novel-tri-specific-t-cell-engager-for-mm","published_at":"2026-02-19T17:00:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/vte-risk-model-in-children-and-a-novel-tri-specific-t-cell-engager-for-mm","url":"https://share.transistor.fm/s/97e8c581","duration_seconds":1021,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/vte-risk-model-in-children-and-a-novel-tri-specific-t-cell-engager-for-mm/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/vte-risk-model-in-children-and-a-novel-tri-specific-t-cell-engager-for-mm.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"CAR-iNKT cell immunotherapy and Jagged2/Notch regulation of HSC","slug":"car-inkt-cell-immunotherapy-and-jagged2-notch-regulation-of-hsc","published_at":"2026-02-12T18:43:14+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/car-inkt-cell-immunotherapy-and-jagged2-notch-regulation-of-hsc","url":"https://share.transistor.fm/s/a342d949","duration_seconds":1210,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/car-inkt-cell-immunotherapy-and-jagged2-notch-regulation-of-hsc/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/car-inkt-cell-immunotherapy-and-jagged2-notch-regulation-of-hsc.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"Biologic Insights and Clinical Trial Design for AML","slug":"biologic-insights-and-clinical-trial-design-for-aml","published_at":"2026-02-05T18:59:00+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/biologic-insights-and-clinical-trial-design-for-aml","url":"https://share.transistor.fm/s/1ae254c6","duration_seconds":1376,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/biologic-insights-and-clinical-trial-design-for-aml/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/biologic-insights-and-clinical-trial-design-for-aml.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]},{"title":"How I Treat Series on Acute Lymphoblastic Leukemia","slug":"how-i-treat-series-on-acute-lymphoblastic-leukemia","published_at":"2026-01-29T18:23:18+00:00","page_url":"https://stenobird.com/podcast/blood-podcast-664776/how-i-treat-series-on-acute-lymphoblastic-leukemia","url":"https://share.transistor.fm/s/411e1898","duration_seconds":1587,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/how-i-treat-series-on-acute-lymphoblastic-leukemia/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/blood-podcast-664776/how-i-treat-series-on-acute-lymphoblastic-leukemia.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}]}